Standard Bank Group Ltd
XBER:SKC2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Standard Bank Group Ltd
XBER:SKC2
|
ZA |
|
A
|
Active Biotech AB publ
STO:ACTI
|
SE |
|
Securitas AB
OTC:SCTBF
|
SE |
|
I
|
Innocan Pharma Corp
XBER:IP4
|
IL |
|
K
|
Kneomedia Ltd
ASX:KNM
|
AU |
|
Canon Electronics Inc
TSE:7739
|
JP |
|
M
|
McDonald's Corp
XHAM:MDO
|
US |
|
M
|
MegaStudyEdu Co Ltd
KOSDAQ:215200
|
KR |
|
Nextensa NV
LSE:0NUT
|
BE |
|
M
|
Maschinenfabrik Heid AG
VSE:HED
|
AT |
|
Novacyt SA
OTC:NVYTF
|
FR |
|
C
|
Crocs Inc
SWB:C7N
|
US |
|
Tomra Systems ASA
F:TMRA
|
NO |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SKC2's stock price target?
Not Available
SKC2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Standard Bank Group Ltd?
Projected CAGR
-8%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is -8%.
What is the Net Income forecast for Standard Bank Group Ltd?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 12%.